Tacrolimus 0.1%

Gel/Cream/Ointment

Tatopic ointment is indicated in adults and adolescents (16 years of age and above)
Flare treatment
Adults and adolescents (16 years of age and above)
Treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids.
Maintenance treatment
Treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i.e. occurring 4 or more times per year) who have had an initial response to a maximum of 6 weeks treatment of twice daily tacrolimus ointment (lesions cleared, almost cleared or mildly affected).

Tatopic ointment should be applied as a thin layer to affected or commonly affected areas of the skin.

Tatopic ointment may be used on any part of the body, including face, neck and flexure areas, except on mucous membranes.

Tatopic ointment should not be applied under occlusion because this method of administration has not been studied in patients